Biotricity News

Biotricity | 8-K: Current report

Apr 3 06:12 ET

Biotricity | 8-K: Current report

Mar 26 17:21 ET

Biotricity | S-1: General form for registration of securities under the Securities Act of 1933

Feb 28 11:54 ET

Biotricity | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Feb 14 17:25 ET

Biotricity | 8-K: Current report

Feb 2 17:32 ET

Biotricity | 8-K: Current report

Nov 6, 2023 16:55 ET

Biotricity | 8-K: Current report

Sep 20, 2023 08:15 ET

Biotricity | 8-K: Biotricity Reports Strong Growth for its First Quarter Fiscal Year 2024 and Provides Financial Results and Business Updates

Aug 17, 2023 08:38 ET

Biotricity | 8-K: Current report

Aug 4, 2023 16:15 ET

Biotricity | 8-K: Current report

Jul 20, 2023 17:14 ET

Biotricity | 8-K: Current report

Jul 5, 2023 16:05 ET

Biotricity | 8-K: Current report

May 18, 2023 16:41 ET

Biotricity | 8-K: Current report

Apr 3, 2023 17:16 ET

Biotricity | DEFA14A: Others

Mar 22, 2023 16:08 ET

Biotricity | DEF 14A: Definitive proxy statements

Mar 13, 2023 16:21 ET

Biotricity | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Mar 2, 2023 14:29 ET

Biotricity | 8-K: Current report

Jan 27, 2023 17:06 ET

Biotricity | 8-K: Current report

Jan 20, 2023 17:27 ET

Biotricity | 8-K: Biotricity Reports Financial Results for Fiscal 2023 Second Quarter Revenue totaled $2.4 million, up 14% sequentially quarter-over-quarter

Nov 18, 2022 12:59 ET

Biotricity | 8-K: Current report

Aug 16, 2022 19:03 ET